This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Ø Investment of £3 million required to complete clinical trial and regulatory approvalsØ Exit opportunities in 3 to 5 years upon completion of 1st clinical study and initial partnership deals
Attractive Business PlanBased on normative Medical Food/FSMP assumptions
20+ years of experience in FMCG and nutrition companies, including:• Formulating and executing corporate
innovation and IP strategies• Starting and growing businesses• Leading multifunctional teams
involving research, marketing, finance, IP and M&A.
(Nestlé, Glycom)
Bruce McConnellChairman of the Board
Simon BaldryCOO
More than 20 years of experience as Managing Director / General Manager in the Food & Drink Industry(Coca Cola, Cadbury)
Larisa Andreeva, PhD, Founder/CEO
25 years experience from biochemresearch and research programmemanagement (Imperial College London, UCL)
Igor Pomytkin, PhD, Founder/Chief Scientist
35+ years experience in neuroscientific research. More than 30 patents to his name (University of Oxford, University of Moscow) of which several have become commercial products.
Galina SkladchikovaPhD, Founder,
Head of IP
20+ years experience in:• Scientific research in the fields of
biochemistry, molecular and cell biology;
• Strategic IP development and management;
• Implementation of IP in innovation and business;
(Glycom, Dako, Hoiberg).Christian Barnes
Dir. Licensing
15yrs experience in product innovation and business development, including BD director of Nestle Health's Science Brain Health platform (Pamlab, Nestle, Akebia)